
Latest Conference Articles
Advertisement


Advertisement




Advertisement


Patrik De Haes, MD, CEO of Oxurion NV, shares the latest updates in clinical studies at the OIS@AAO meeting in Chicago, Oct. 2018.

Chuck Hess provides a company update at the OIS@AAO meeting in Chicago, Oct. 2018.

Erin D. Stahl, MD, discusses why it's important to diagnose and treat children with keratoconus at the earliest signs of development for successful outcomes during the AAO 2018 meeting in Chicago.
Advertisement

Elad Kedar, CEO of Orasis Pharmaceuticals, provides a company update at OIS@AAO 2018 in Chicago.









Joint event to feature plenty of symposia, practice management programs, product innovations

Sunir J. Garg, MD, discusses hypersonic vitrector settings in surgery in the exhibition hall at ASRS 2018 in Vancouver.









Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
FDA approves phentolamine ophthalmic solution 0.75% (Ryzumvi) for presbyopia
2
Duravyu misses noninferiority end point in phase 3 LUCIA wet AMD trial
3
Beyond slowing atrophy: Optogenetic therapy targets vision lost to GA
4
AAO 2026: Rethinking dry eye as a spectrum of ocular pain
5